Coloplast A/S Statistics
Share Statistics
Coloplast A/S has 2.27B
shares outstanding. The number of shares has increased by 2.06%
in one year.
| Shares Outstanding | 2.27B |
| Shares Change (YoY) | 2.06% |
| Shares Change (QoQ) | 0.25% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 405 |
| FTD / Avg. Volume | 0.18% |
Short Selling Information
The latest short interest is 62.16K, so 0% of the outstanding
shares have been sold short.
| Short Interest | 62.16K |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is 39.01 and the forward
PE ratio is 3.2.
Coloplast A/S's PEG ratio is
34.66.
| PE Ratio | 39.01 |
| Forward PE | 3.2 |
| PS Ratio | 7.29 |
| Forward PS | 0.5 |
| PB Ratio | 10.98 |
| P/FCF Ratio | 123.18 |
| PEG Ratio | 34.66 |
Financial Ratio HistoryEnterprise Valuation
Coloplast A/S has an Enterprise Value (EV) of 41.55B.
| EV / Sales | 1.54 |
| EV / EBITDA | 4.9 |
| EV / EBIT | 15.02 |
| EV / FCF | 25.97 |
Financial Position
The company has a current ratio of 1.02,
with a Debt / Equity ratio of 1.26.
| Current Ratio | 1.02 |
| Quick Ratio | 0.66 |
| Debt / Equity | 1.26 |
| Debt / EBITDA | 2.67 |
| Debt / FCF | 14.14 |
| Interest Coverage | 8.3 |
Financial Efficiency
Return on Equity is 28.16% and Return on Invested Capital is 13.38%.
| Return on Equity | 28.16% |
| Return on Assets | 10.51% |
| Return on Invested Capital | 13.38% |
| Revenue Per Employee | $1,614,598.89 |
| Profits Per Employee | $301,774.09 |
| Employee Count | 16,741 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 2.39 |
Taxes
| Income Tax | 1.34B |
| Effective Tax Rate | 21% |
Stock Price Statistics
The stock price has increased by -21.24% in the
last 52 weeks. The beta is 0.55, so Coloplast A/S's
price volatility has been higher than the market average.
| Beta | 0.55 |
| 52-Week Price Change | -21.24% |
| 50-Day Moving Average | 10.18 |
| 200-Day Moving Average | 11.68 |
| Relative Strength Index (RSI) | 34.69 |
| Average Volume (20 Days) | 221,922 |
Income Statement
In the last 12 months, Coloplast A/S had revenue of 27.03B
and earned 5.05B
in profits. Earnings per share was 2.25.
| Revenue | 27.03B |
| Gross Profit | 18.27B |
| Operating Income | 7.32B |
| Net Income | 5.05B |
| EBITDA | 8.48B |
| EBIT | 7.19B |
| Earnings Per Share (EPS) | 2.25 |
Full Income StatementBalance Sheet
The company has 788M in cash and 22.63B in
debt, giving a net cash position of -21.84B.
| Cash & Cash Equivalents | 788M |
| Total Debt | 22.63B |
| Net Cash | -21.84B |
| Retained Earnings | 15.39B |
| Total Assets | 49.15B |
| Working Capital | -500M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 2.77B
and capital expenditures -1.17B, giving a free cash flow of 1.6B.
| Operating Cash Flow | 2.77B |
| Capital Expenditures | -1.17B |
| Free Cash Flow | 1.6B |
| FCF Per Share | 7.11 |
Full Cash Flow StatementMargins
Gross margin is 67.59%, with operating and profit margins of 27.08% and 18.69%.
| Gross Margin | 67.59% |
| Operating Margin | 27.08% |
| Pretax Margin | 23.66% |
| Profit Margin | 18.69% |
| EBITDA Margin | 31.37% |
| EBIT Margin | 27.08% |
| FCF Margin | 5.92% |
